Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma

Clinical Radiology

Volumn 66, Issue 3, 2011, Pages 224-236

  Patnana, M ^a   Bronstein, Y ^a   Szklaruk, J ^a   Bedi, D G ^a   Hwu, W J ^a   Gershenwald, J E ^a   Prieto, V G ^a   Ng, C S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CISPLATIN; DACARBAZINE; IMMUNOMODULATING AGENT; INTERLEUKIN 2; TEMOZOLOMIDE; VINBLASTINE;

BRAIN METASTASIS; CANCER CLASSIFICATION; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; GALLBLADDER METASTASIS; GENITOURINARY METASTASIS; GENITOURINARY TRACT METASTASIS; HEART METASTASIS; HUMAN; IMAGE ANALYSIS; LIVER METASTASIS; LYMPH NODE METASTASIS; MELANOMA; MESENTERY METASTASIS; METASTASIS; MUSCULOSKELETAL METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS METASTASIS; PATHOLOGY; PATIENT ASSESSMENT; PERITONEUM METASTASIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SKIN METASTASIS; SUBCUTANEOUS TISSUE; TREATMENT RESPONSE; VISCERAL METASTASIS;

FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; SKIN NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79551591503     PISSN: 00099260     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crad.2010.10.014     Document Type: Review

References (96)

1. C.M. Balch, J.E. Gershenwald, and S.J. Soong Final version of 2009 AJCC melanoma staging and classification J Clin Oncol 27 2009 6199 6206
2. C.M. Balch, J.E. Gershenwald, and S.J. Soong Melanoma of the skin S.E. Edge, D.R. Byrd, M.A. Carducci, C.A. Compton, American joint committee on cancer staging manual 7th ed 2010 Springer New York, NY p. 387-415
3. American Cancer Society Skin cancer facts 6 July, 2009 Available at: http://www.cancer.org/docroot/ped/content/ped-7-1-what-you-need-to-know-about- skin-cancer.asp ; [Accessed 07 02 2010]
4. Cancer Research UK Skin cancer - UK incidence statistics 20 May, 2010 Available at: http://info.cancerresearchuk.org/cancerstats/types/skin/incidence/ index.htm [Accessed 10 07 2010]
5. D.M. King Imaging of metastatic melanoma Cancer Imaging 6 2006 204 208
6. I.R. Kamel, J.B. Kruskal, and H.F. Gramm Imaging of abdominal manifestations of melanoma Crit Rev Diagn Imaging 39 1998 447 486
7. D. Ost, C. Joseph, and H. Sogoloff Primary pulmonary melanoma: case report and literature review Mayo Clin Proc 74 1999 62 66
8. P. DeMatos, W.G. Wolfe, and C.R. Shea Primary malignant melanoma of the esophagus J Surg Oncol 66 1997 201 206
9. A.A. Sanchez, T.T. Wu, and V.G. Prieto Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases Arch Pathol Lab Med 132 2008 1623 1629
10. X.D. Dong, P. DeMatos, and V.G. Prieto Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center Cancer 85 1999 32 39
11. D.G. Coit, R. Andtbacka, and C.K. Bichakjian Melanoma J Natl Compr Canc Netw 7 2009 250 275
12. J.E. Gershenwald, W. Thompson, and P.F. Mansfield Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 1999 976 983
13. A. Breslow Tumor thickness, level of invasion and node dissection in stage I cutaneous melanoma Ann Sug 182 1975 572 575
14. W.H.J. Clark, D.E. Elder, and D. Guerry 4th A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma Hum Pathol 15 1984 1147 1165
15. J.E. Gershenwald, C.M. Balch, and S. Soong Prognostic factors and natural history of melanoma C.M. Balch, A.N. Houghton, A.J. Sober, S. Soong, M.B. Atkins, J.F. Thompson, Cutaneous melanoma 2009 Quality Medical Publishing St Louis, MO 35 64
16. J.E. Gershenwald, J.F. Thompson, and N. Mozzilo Intraoperative mapping and sentinel node technology in patients with melanoma C.M. Balch, A.N. Houghton, A.J. Sober, S. Soong, M.B. Atkins, J.F. Thompson, Cutaneous melanoma 2009 Quality Medical Publishing St Louis, MO 415 446
17. C.M. Balch, J.E. Gershenwald, and S. Soong Melanoma staging and classification C.M. Balch, A.N. Houghton, A.J. Sober, S. Soong, M.B. Atkins, J.F. Thompson, Cutaneous melanoma 2009 Quality Medical Publishing St Louis, MO 65 85
18. V.G. Prieto, and C.R. Shea Use of immunohistochemistry in melanocytic lesions J Cutan Pathol 35 Suppl. 2 2008 1 10
19. E.A. Choi, and J.E. Gershenwald Imaging studies in patients with melanoma Surg Oncol Clin N Am 16 2007 403 430
20. K. Strobel, R. Dummer, and D.B. Husarik High-risk melanoma: accuracy of FDG PET/CT with added CT morphologic information for detection of metastases Radiology 244 2007 566 574
21. Y. Xing, Y. Bronstein, and M.I. Ross Diagnostic imaging modalities for the surveillance of melanoma patients: a meta-analysis J Clin Oncol 28 2010 15s 2010 ASCO Meeting Proceedings Part I
22. D.S. Tyler, M. Onaitis, and A. Kherani Positron emission tomography scanning in malignant melanoma Cancer 89 2000 1019 1025
23. S.E. Finkelstein, J.A. Carrasquillo, and J.M. Hoffman A prospective analysis of positron emission tomography and conventional imaging for detection of stage IV metastatic melanoma in patients undergoing metastasectomy Ann Surg Oncol 11 2004 731 738
24. 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma Eur J Cancer 43 2007 557 564
25. S.A. Gulec, M.B. Faries, and C.C. Lee The role of fluorine-18 deoxyglucose positron emission tomography in the management of patients with metastatic melanoma: impact on surgical decision making Clin Nucl Med 28 2003 961 965
26. M.T. Harris, S.U. Berlangieri, and J.S. Cebon Impact of 2-deoxy-2[F-18]fluoro-D-glucose positron emission tomography on the management of patients with advanced melanoma Mol Imaging Biol 7 2005 304 308
27. 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients J Clin Oncol 24 2006 1178 1187
28. M.S. Brady, T. Akhurst, and K. Spanknebel Utility of preoperative [18]f fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients Ann Surg Oncol 13 2006 525 532
29. L.N. Nazarian, A.A. Alexander, and A.B. Kurtz Superficial melanoma metastases: appearances on gray-scale and color Doppler sonography AJR Am J Roentgenol 170 1998 459 463
30. J.H. Sampson, J.H. Carter Jr., and A.H. Friedman Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma J Neurosurg 88 1998 11 20
31. P.Y. Wen, P.M. Black, and J.S. Loeffler Treatment of metastatic brain cancer V.T. DeVita Jr. S. Hellman, S.A. Rosenberg, Cancer: principles and practice of oncology 2001 Lippincott Williams & Wilkins Philadelphia, PA p. 2655-2670
32. A.G. Osborn Part III, brain tumors and tumorlike processes A.S. Patterson, Diagnostic neuroradiology 1994 Mosby St Louis, MO 656 670
33. E.J. Escott A variety of appearances of malignant melanoma in the head: a review RadioGraphics 21 2001 625 639
34. P.D. Schellinger, H.M. Meinck, and A. Thron Diagnostic accuracy of MRI compared to CCT in patients with brain metastases J Neurooncol 44 1999 275 281
35. I. Isiklar, N.E. Leeds, G.N. Fuller, and A.J. Kumar Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content AJR Am J Roentgenol 165 1995 1503 1512
36. W.W. Woodruff Jr., W.T. Djang, and R.E. McLendon Intracerebral malignant melanoma: high-field-strength MR imaging Radiology 165 1987 209 213
37. H.F. Marx, P.M. Colletti, and J.K. Raval Magnetic resonance imaging features in melanoma Magn Reson Imaging 8 1990 223 229
38. S.M. Hammersmith, M.R. Terk, and P.B. Jeffrey Magnetic resonance imaging of nasopharyngeal and paranasal sinus melanoma Magn Reson Imaging 8 1990 245 253
39. G.M. McGann, and A. Platts Computed tomography of cranial metastatic malignant melanoma: features, early detection and unusual cases Br J Radiol 64 1991 310 313
40. L.C. Hartmann, G.F. Oliver, and R.K. Winkelmann Blue nevus and nevus of Ota associated with dural melanoma Cancer 64 1989 182 186
41. P. Theunissen, G. Spincemaille, and M. Pannebakker Meningeal melanoma associated with nevus of Ota: case report and review Clin Neuropathol 12 1993 125 129
42. R.K. Narayan, M.J. Rosner, and J.T. Povlishock Primary dural melanoma: a clinical and morphological study Neurosurgery 9 1981 710 717
43. B. Ozden, O. Barlas, and U. Hacihanefioglu Primary dural melanomas: report of two cases and review of the literature Neurosurgery 15 1984 104 107
44. W.M. Stephenson, and A.L. Merlis Computed tomography of primary melanoma of the leptomeninges: case reports J Comput Tomogr 9 1985 337 342
45. J.P. Glass, M. Melamed, and N.L. Chernik Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology Neurology 29 1979 1369 1375
46. R.J. Freilich, G. Krol, and L.M. DeAngelis Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis Ann Neurol 38 1995 51 57
47. E. Paakko, N.J. Patronas, and D. Schellinger Meningeal Gd-DTPA enhancement in patients with malignancies J Comput Assist Tomogr 14 1990 542 546
48. G. Sze, S. Soletsky, and R. Bronen MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis AJNR Am J Neuroradiol 10 1989 965 975 (Pubitemid 19219644)
49. C.S. Straathof, H.G. de Bruin, and D.W. Dippel The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis J Neurol 246 1999 810 814
50. J.A. Pain, D.S. Collier, and P.C. Conn Malignant melanoma of a parotid lymph gland. an unusual case Int J Oral Maxillofac Surg 15 1986 645 647
51. M. Bahar, Y. Anavi, and A. Abraham Primary malignant melanoma in the parotid gland Oral Surg Oral Med Oral Pathol 70 1990 627 630
52. G.W. Greene Jr., and J.L. Bernier Primary malignant melanomas of the parotid gland Oral Surg Oral Med Oral Pathol 14 1961 108 116
53. M.J. Yeung, and J.W. Serpell Management of the solitary thyroid nodule Oncologist 13 2008 105 112
54. P.C. Chang, N.J. Fischbein, and T.H. McCalmont Perineural spread of malignant melanoma of the head and neck: clinical and imaging features AJNR Am J Neuroradiol 25 2004 5 11
55. J.K. Patel, M.S. Didolkar, and J.W. Pickren Metastatic pattern of malignant melanoma. a study of 216 autopsy cases Am J Surg 135 1978 807 810
56. J.T. Chen, N.S. Dahmash, and C.E. Ravin Metastatic melanoma in the thorax: report of 130 patients AJR Am J Roentgenol 137 1981 293 298
57. E.K. Fishman, J.E. Kuhlman, and L.M. Schuchter CT of malignant melanoma in the chest, abdomen, and musculoskeletal system RadioGraphics 10 1990 603 620
58. L.E. Quint, C.H. Park, and M.D. Iannettoni Solitary pulmonary nodules in patients with extrapulmonary neoplasms Radiology 217 2000 257 261
59. A. Salud, J.M. Porcel, and A. Rovirosa Endobronchial metastatic disease: analysis of 32 cases J Surg Oncol 62 1996 249 252
60. A.N. Leung, N.L. Muller, and R.R. Miller CT in differential diagnosis of diffuse pleural disease AJR Am J Roentgenol 154 1990 487 492
61. D.D. Paulus, and H.I. Libshitz Metastasis to the breast Radiol Clin North Am 20 1982 561 568
62. T.A. Klingen, H. Klaasen, and H. Aas Secondary breast cancer: a 5-year population-based study with review of the literature APMIS 117 2009 762 767
63. K.Y. Lam, P. Dickens, and A.C. Chan Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies Arch Pathol Lab Med 117 1993 1027 1031
64. K. Mukai, T. Shinkai, and K. Tominaga The incidence of secondary tumors of the heart and pericardium: a 10-year study Jpn J Clin Oncol 18 1988 195 201
65. K.P. Abraham, V. Reddy, and P. Gattuso Neoplasms metastatic to the heart: review of 3314 consecutive autopsies Am J Cardiovasc Pathol 3 1990 195 198
66. E.C. Klatt, and D.R. Heitz Cardiac metastases Cancer 65 1990 1456 1459
67. C. Chiles, P.K. Woodard, and F.R. Gutierrez Metastatic involvement of the heart and pericardium: CT and MR imaging RadioGraphics 21 2001 439 449
68. P. Savoia, M.T. Fierro, and A. Zaccagna Metastatic melanoma of the heart J Surg Oncol 75 2000 203 207
69. S. Bakalian, J.C. Marshall, and P. Logan Molecular pathways mediating liver metastasis in patients with uveal melanoma Clin Cancer Res 14 2008 951 956
70. R. Kath, J. Hayungs, and N. Bornfeld Prognosis and treatment of disseminated uveal melanoma Cancer 72 1993 2219 2223
71. J.G. Lorigan, S. Wallace, and G.M. Mavligit The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients AJR Am J Roentgenol 157 1991 1279 1281
72. S. Rajpal, R. Moore, and C.P. Karakousis Survival in metastatic ocular melanoma Cancer 52 1983 334 336
73. B. Peruzzi, and D.P. Bottaro Targeting the c-Met signaling pathway in cancer Clin Cancer Res 12 2006 3657 3660
74. K.D. Burkill Gjc Malignant tumours of the skin J.E. Husband, R.H. Reznek, Imaging in oncology 2004 Taylor and Francis Boca Raton, FL 1149 1168
75. E. Kalkman, and G. Baxter Melanoma Clin Radiol 59 2004 313 326
76. A. Shirkhoda, and J. Albin Malignant melanoma: correlating abdominal and pelvic CT with clinical staging Radiology 165 1987 75 78
77. P.M. Silverman, D.K. Heaston, and M. Korobkin Computed tomography in the detection of abdominal metastases from malignant melanoma Invest Radiol 19 1984 309 312
78. S. Sheth, K.M. Horton, and M.R. Garland Mesenteric neoplasms: CT appearances of primary and secondary tumors and differential diagnosis RadioGraphics 23 2003 457 473 quiz 535-456
79. N. Ricaniadis, M.M. Konstadoulakis, and D. Walsh Gastrointestinal metastases from malignant melanoma Surg Oncol 4 1995 105 110
80. J. Twersky, and D.C. Levin Metastatic melanoma of the adrenal: an unusual cause of adrenal calcification Radiology 116 1975 627 628
81. M. Korobkin, T.J. Lombardi, and A.M. Aisen Characterization of adrenal masses with chemical shift and gadolinium-enhanced MR imaging Radiology 197 1995 411 418
82. R.B. Bracken, G. Chica, and D.E. Johnson Secondary renal neoplasms: an autopsy study South Med J 72 1979 806 807
83. N.B. Kumar, and W.R. Hart Metastases to the uterine corpus from extragenital cancers. a clinicopathologic study of 63 cases Cancer 50 1982 2163 2169
84. P. Potepan, I. Spagnoli, and G.M. Danesini The radiodiagnosis of bone metastases from melanoma Radiol Med 87 1994 741 746
85. A. Aydin, J.Q. Yu, and H. Zhuang Detection of bone marrow metastases by FDG-PET and missed by bone scintigraphy in widespread melanoma Clin Nucl Med 30 2005 606 607
86. H. Yoshioka, Y. Itai, and M. Niitsu Intramuscular metastasis from malignant melanoma: MR findings Skeletal Radiol 28 1999 714 716
87. J.E. Gershenwald, and P. Hwu Melanoma W.K. Hong, R.C. Bast Jr. W. Hait, Cancer medicine 2010 Shelton: Peoples Medical Publishing House
88. E. Chang, and S.A. Rosenberg Patients with melanoma metastases at cutaneous and subcutaneous sites are highly susceptible to interleukin-2-based therapy J Immunother 24 2001 88 90
89. A.Y. Bedikian, M.M. Johnson, and C.L. Warneke Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival J Immunotoxicol 5 2008 201 207
90. A.Y. Bedikian, M.M. Johnson, and C.L. Warneke Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma Cancer Invest 26 2008 624 633
91. S. ODay, F.S. Hodi, and D.F. McDermott A phase III, randomized, double-blind, multicenter study comparing monotherapy with ipilimumab or gp100 peptide vaccine and the combination in patients with previously treated, unresectable stage III or IV melanoma J Clin Oncol 28 2010 6s 2010 ASCO Meeting Proceedings Part I
92. Flaherty K, Puzanov I, Sosman J, et al. Phase I study of PLX4032: proof of concept for V600E BRAF mutation as a therapeutic target in human cancer, ASCO MEETING ABSTRACTS Jun 8, 2009, abstract number 9000.
93. M.T. Ballo, and K.K. Ang Radiation therapy for malignant melanoma Surg Clin North Am 83 2003 323 342
94. G. Stevens, and M.J. McKay Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma Lancet Oncol 7 2006 575 583
95. E.A. Eisenhauer, P. Therasse, and J. Bogaerts New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) Eur J Cancer 45 2009 228 247
96. D.J. Sargent, L. Rubinstein, and L. Schwartz Validation of novel imaging methodologies for use as cancer clinical trial end-points Eur J Cancer 45 2009 290 299